XPhyto Therapeutics Corp. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was CAD 84,622 compared to CAD 45,072 a year ago. Operating loss was CAD 4.948 million compared to CAD 3.684 million a year ago. Net loss was CAD 6.801 million compared to CAD 3.731 million a year ago. Basic loss per share from continuing operations was CAD 0.11 compared to CAD 0.08 a year ago. For the nine months, sales was CAD 268,324 compared to CAD 45,072 a year ago. Operating loss was CAD 12.111 million compared to CAD 5.351 million a year ago. Net loss was CAD 14.082 million compared to CAD 5.477 million a year ago. Basic loss per share from continuing operations was CAD 0.25 compared to CAD 0.12 a year ago.